Table 1 of
Magaña-Guerrero, Mol Vis 2025; 31:368-378. Table 1 of
Magaña-Guerrero, Mol Vis 2025; 31:368-378.
Table 1. Demographic and clinical data of the subjects enrolled in the study.
| Diabetes (DM) | |||
|---|---|---|---|
| Surrogate controls | Macular edema | Proliferative DR | |
| Demographics | |||
| n | 8 | 8 | 15 |
| Sex (F:M) | 6/2 | 5/3 | 7/8 |
| Age (±SD) | 61.7(±4.3) | 61.4(±6.0) | 57.2(±11.5) |
| DM evolution (years) | 13.8(±6.7) | 19.4(±7.0) | |
| Clinical biochemistry | |||
| Cholesterol (mg/dl) | 192.8 (±35.7) | 185.3 (±35.3) | 176 (±59) |
| Triglycerides (mg/dl) | 128.9 (±28.9) | 178.6 (±63.0) | 210.5 (±52.6) |
| Creatinine (mg/dl) | 0.74 (±0.14) | 1.1 (±0.5) | 1.6 (±0.6) |
| Hematological Inflammatory Ratios | |||
| NLR | 1.33 | 2.50 (*p=0.04) | 3.60 (*p=0.03) |
| PLR | 134 | 156 (p=0.28) | 131 (p=0.46) |
| MLR | 0.18 | 0.3 (*p=0.01) | 0.36 (*p=0.01) |